Page CP - Search Results

1

Current and future developments in the pharmacology of asthma and COPD: ERS seminar, Naples 2022.

Stolz D, Matera MG, Rogliani P, van den Berge M, Papakonstantinou E, Gosens R, Singh D, Hanania N, Cazzola M, Maitland-van der Zee AH, Fregonese L, Mathioudakis AG, Vestbo J, Rukhadze M, Page CP. Stolz D, et al. Among authors: page cp. Breathe (Sheff). 2023 Jun;19(2):220267. doi: 10.1183/20734735.0267-2022. Epub 2023 Jun 13. Breathe (Sheff). 2023. PMID: 37377851 Free PMC article. Review.

2

Alternative and/or integrative therapies for pneumonia under development.

Cazzola M, Page CP, Matera MG. Cazzola M, et al. Among authors: page cp. Curr Opin Pulm Med. 2004 May;10(3):204-10. doi: 10.1097/00063198-200405000-00010. Curr Opin Pulm Med. 2004. PMID: 15071372 Review.

3

The safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot study.

Hanania NA, Singh S, El-Wali R, Flashner M, Franklin AE, Garner WJ, Dickey BF, Parra S, Ruoss S, Shardonofsky F, O'Connor BJ, Page C, Bond RA. Hanania NA, et al. Pulm Pharmacol Ther. 2008;21(1):134-41. doi: 10.1016/j.pupt.2007.07.002. Epub 2007 Jul 17. Pulm Pharmacol Ther. 2008. PMID: 17703976 Free PMC article. Clinical Trial.

4

Treating systemic effects of COPD.

Cazzola M, Matera MG, Rogliani P, Page C. Cazzola M, et al. Trends Pharmacol Sci. 2007 Oct;28(10):544-50. doi: 10.1016/j.tips.2007.09.006. Epub 2007 Sep 27. Trends Pharmacol Sci. 2007. PMID: 17897727 Free article. Review.

5

Effects of neuraminidase on equine isolated bronchi.

Matera MG, Calzetta L, Sanduzzi A, Page CP, Cazzola M. Matera MG, et al. Among authors: page cp. Pulm Pharmacol Ther. 2008 Aug;21(4):624-9. doi: 10.1016/j.pupt.2008.02.003. Epub 2008 Feb 26. Pulm Pharmacol Ther. 2008. PMID: 18394940

6

The therapeutic efficacy of erdosteine in the treatment of chronic obstructive bronchitis: a meta-analysis of individual patient data.

Cazzola M, Floriani I, Page CP. Cazzola M, et al. Among authors: page cp. Pulm Pharmacol Ther. 2010 Apr;23(2):135-44. doi: 10.1016/j.pupt.2009.10.002. Epub 2009 Oct 23. Pulm Pharmacol Ther. 2010. PMID: 19854285 Review.

7

Epithelium integrity is crucial for the relaxant activity of brain natriuretic peptide in human isolated bronchi.

Matera MG, Calzetta L, Passeri D, Facciolo F, Rendina EA, Page C, Cazzola M, Orlandi A. Matera MG, et al. Br J Pharmacol. 2011 Aug;163(8):1740-54. doi: 10.1111/j.1476-5381.2011.01339.x. Br J Pharmacol. 2011. PMID: 21410689 Free PMC article.

8

Preclinical evaluation of an inhibitor of cytosolic phospholipase A2α for the treatment of asthma.

Hewson CA, Patel S, Calzetta L, Campwala H, Havard S, Luscombe E, Clarke PA, Peachell PT, Matera MG, Cazzola M, Page C, Abraham WM, Williams CM, Clark JD, Liu WL, Clarke NP, Yeadon M. Hewson CA, et al. J Pharmacol Exp Ther. 2012 Mar;340(3):656-65. doi: 10.1124/jpet.111.186379. Epub 2011 Dec 7. J Pharmacol Exp Ther. 2012. PMID: 22160268

9

Long-acting muscarinic receptor antagonists for the treatment of respiratory disease.

Cazzola M, Page C, Matera MG. Cazzola M, et al. Pulm Pharmacol Ther. 2013 Jun;26(3):307-17. doi: 10.1016/j.pupt.2012.12.006. Epub 2012 Dec 27. Pulm Pharmacol Ther. 2013. PMID: 23274274 Review.

10

Brain natriuretic peptide protects against hyperresponsiveness of human asthmatic airway smooth muscle via an epithelial cell-dependent mechanism.

Calzetta L, Passeri D, Kanabar V, Rogliani P, Page C, Cazzola M, Matera MG, Orlandi A. Calzetta L, et al. Am J Respir Cell Mol Biol. 2014 Mar;50(3):493-501. doi: 10.1165/rcmb.2013-0119OC. Am J Respir Cell Mol Biol. 2014. PMID: 24074453

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

464 results

Search Page